Prognostic Significance and Determinantsof the 6-Min Walk Test inPatients WithHeart Failure and Preserved EjectionFraction

JACC: Heart Failure

Volumn 3, Issue 6, 2015, Pages 459-466

  Zotter Tufaro, Caroline ^a   Mascherbauer, Julia ^a   Duca, Franz ^a   Koell, Benedikt ^a   Aschauer, Stefan ^a   Kammerlander, Andreas A ^a   Panzenboeck, Adelheid ^a   Sadushi Kolici, Roela ^a   Bangert, Christine ^b   Laimer, Daniela ^b   Ristl, Robin ^a   Lang, Irene M ^a   Bonderman, Diana ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

Cardiac catheterization; Exercise test; Extracellular matrix; Pulmonary circulation

Indexed keywords

6 MINUTE WALK DISTANCE; AGED; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; DISEASE ASSOCIATION; DYSPNEA; EXERCISE INTENSITY; EXERCISE TOLERANCE; EXTRACELLULAR MATRIX; FATIGUE; FEMALE; FOLLOW UP; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; WALKING; EXERCISE TEST; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; CARDIAC CATHETERIZATION; EXERCISE TEST; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; WALKING;

EID: 84930858114     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.01.010     Document Type: Article

References (40)

1. Hogg K., Swedberg K., McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. JAm Coll Cardiol 2004, 43:317-327.
2. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. NEngl J Med 2006, 355:260-269.
3. Smith G.L., Masoudi F.A., Vaccarino V., Radford M.J., Krumholz H.M. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. JAm Coll Cardiol 2003, 41:1510-1518.
4. Zile M.R., Baicu C.F., Gaasch W.H. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. NEngl J Med 2004, 350:1953-1959.
5. Martos R., Baugh J., Ledwidge M., et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007, 115:888-895.
6. Haddad F., Kudelko K., Mercier O., Vrtovec B., Zamanian R.T., de Jesus Perez V. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies. Prog Cardiovasc Dis 2011, 54:154-167.
7. Lipkin D.P., Scriven A.J., Crake T., Poole-Wilson P.A. Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) 1986, 292:653-655.
8. Ingle L., Rigby A.S., Carroll S., et al. Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure. Eur Heart J 2007, 28:560-568.
9. Bittner V., Weiner D.H., Yusuf S., et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993, 270:1702-1707.
10. Mangla A., Kane J., Beaty E., Richardson D., Powell L.H., Calvin J.E. Comparison of predictors of heart failure-related hospitalization or death in patients with versus without preserved left ventricular ejection fraction. Am J Cardiol 2013, 112:1907-1912.
11. Rasekaba T., Lee A.L., Naughton M.T., Williams T.J., Holland A.E. The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J 2009, 39:495-501.
12. Pinto-Plata V.M., Cote C., Cabral H., Taylor J., Celli B.R. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004, 23:28-33.
13. Paulus W.J., Tschope C., Sanderson J.E., et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007, 28:2539-2550.
14. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. JAm Coll Cardiol 2013, 62:e147-e239.
15. Galie N., Hoeper M.M., Humbert M., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009, 30:2493-2537.
16. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.
17. Borg G.A. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982, 14:377-381.
18. Garvey W., Fathi A., Bigelow F., Carpenter B., Jimenez C. Acombined elastic, fibrin and collagen stain. Stain Technol 1987, 62:365-368.
19. Miyamoto S., Nagaya N., Satoh T., et al. Clinicalcorrelates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000, 161:487-492.
20. Abudiab M.M., Redfield M.M., Melenovsky V., et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail 2013, 15:776-785.
21. Thenappan T., Shah S.J., Gomberg-Maitland M., et al. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Fail 2011, 4:257-265.
22. Zile M.R., Kjellstrom B., Bennett T., et al. Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction. Circ Heart Fail 2013, 6:508-516.
23. Borlaug B.A., Olson T.P., Lam C.S., et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. JAm Coll Cardiol 2010, 56:845-854.
24. Franchi F., Knudsen B.E., Oehler E., et al. Non-invasive assessment of cardiac function in a mouse model of renovascular hypertension. Hypertens Res 2013, 36:770-775.
25. Westermann D., Lindner D., Kasner M., et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 2011, 4:44-52.
26. Paulus W.J., Tschope C. Anovel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. JAm Coll Cardiol 2013, 62:263-271.
27. Garcia C., Feve B., Ferre P., et al. Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab 2010, 36:327-338.
28. Agusti A., Edwards L.D., Rennard S.I., et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012, 7:e37483.
29. Shlipak M.G., Fried L.F., Crump C., et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003, 107:87-92.
30. Haykowsky M.J., Brubaker P.H., Stewart K.P., Morgan T.M., Eggebeen J., Kitzman D.W. Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. JAm Coll Cardiol 2012, 60:120-128.
31. Kitzman D.W., Brubaker P.H., Herrington D.M., et al. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. JAm Coll Cardiol 2013, 62:584-592.
32. Haykowsky M.J., Brubaker P.H., John J.M., Stewart K.P., Morgan T.M., Kitzman D.W. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. JAm Coll Cardiol 2011, 58:265-274.
33. Bhella P.S., Prasad A., Heinicke K., et al. Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail 2011, 13:1296-1304.
34. Fujimoto N., Prasad A., Hastings J.L., et al. Cardiovascular effects of 1 year of progressive endurance exercise training in patients with heart failure with preserved ejection fraction. Am Heart J 2012, 164:869-877.
35. Haykowsky M.J., Brubaker P.H., Morgan T.M., Kritchevsky S., Eggebeen J., Kitzman D.W. Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass. JGerontol A Biol Sci Med Sci 2013, 68:968-975.
36. Haykowsky M.J., Kouba E.J., Brubaker P.H., Nicklas B.J., Eggebeen J., Kitzman D.W. Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Cardiol 2014, 113:1211-1216.
37. Kitzman D.W., Nicklas B., Kraus W.E., et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol 2014, 306:H1364-H1370.
38. Sousa-Victor P., Gutarra S., Garcia-Prat L., et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 2014, 506:316-321.
39. Sinha M., Jang Y.C., Oh J., et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 2014, 344:649-652.
40. Provencher S., Herve P., Jais X., et al. Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension. Gastroenterology 2006, 130:120-126.